Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04024163 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv4
  2. Primary completion date: Aug 30, 2026 to Aug 30, 2027v3 Show 5 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 164 to confirmed 178
    • Study sites: 8 to 9
    • Study completion date: Mar 2, 2027 to Mar 30, 2028
    • Collaborator revised
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 8
    • Start date changed from estimate of Aug 30, 2019 to Sep 19, 2019
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study evaluate the efficacy and safety of benznidazole in the treatment of chronic indeterminate Chagas disease in children. All subjects will receive benznidazole and results will be compared to historically to a placebo arm.
Trial Details
NCT Number NCT04024163
Lead Sponsor Insud Pharma
Collaborators: Chemo Research
Conditions
(from sponsor)		 Chagas Disease
Related terms Chagas Disease
Enrollment 178 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov